AIHCC
Index Performance
-1.83%
AIHCC
-5.44%
NBI
-5.46%
ICEBIOT
Overview
Description
The Intelligent Healthcare Conviction strategy (AIHC) uses OpenAI's ChatGPT, Google's Bard, and Inflection AI's Claude to build an equal weighted portfolio of the committee's highest conviction US-listed stocks in the healthcare sector. The strategy aims to create superior quality-focused returns compared to the MSCI US Investable Market Health Care 25/50 Index.
- TickerAIHCC
- Inception Date10/16/2023
- WeightingEqual
- # of holdings30
What's inside?
Holdings
All holdings as of December 1, 2023
CSV download
| DexCom, Inc. (DXCM) | 4.66% | $45.283B | 26.69% | 63.75% | 11.55x |
| Insulet Corp. (PODD) | 4.37% | $13.347B | 26.97% | 68.36% | 8.01x |
| Intuitive Surgical, Inc. (ISRG) | 3.68% | $108.973B | 11.96% | 66.94% | 14.35x |
| ResMed, Inc. (RMD) | 3.62% | $23.674B | 16.00% | 53.30% | 5.28x |
| Boston Scientific Corp. (BSX) | 3.58% | $80.398B | 11.26% | 61.44% | 6.28x |
| Stryker Corp. (SYK) | 3.57% | $110.363B | 9.60% | 61.52% | 5.84x |
| Zimmer Biomet Holdings, Inc. (ZBH) | 3.57% | $24.204B | 5.02% | 60.83% | 3.95x |
| IDEXX Laboratories, Inc. (IDXX) | 3.56% | $43.100B | 8.78% | 59.72% | 10.46x |
| Penumbra, Inc. (PEN) | 3.55% | $8.526B | 26.80% | 64.67% | 9.51x |
| Medtronic Plc (MDT) | 3.53% | $104.803B | 5.26% | 60.10% | 3.44x |
| Danaher Corp. (DHR) | 3.40% | $162.150B | -10.31% | 58.20% | 6.63x |
| GE Healthcare Technologies, Inc. (GEHC) | 3.34% | $30.925B | N/A | 39.03% | 2.03x |
| Elevance Health, Inc. (ELV) | 3.34% | $113.262B | 7.29% | N/A | 0.76x |
| Hologic, Inc. (HOLX) | 3.32% | $16.623B | -0.84% | 52.27% | 4.30x |
| Thermo Fisher Scientific, Inc. (TMO) | 3.29% | $189.941B | -0.96% | 40.97% | 5.20x |
| UnitedHealth Group, Inc. (UNH) | 3.28% | $508.949B | 14.18% | N/A | 1.51x |
| Johnson & Johnson (JNJ) | 3.26% | $381.674B | -10.36% | 69.53% | 4.23x |
| Merck & Co., Inc. (MRK) | 3.19% | $269.189B | 5.20% | 70.74% | 4.96x |
| Edwards Lifesciences Corp. (EW) | 3.13% | $41.758B | 12.27% | 75.71% | 7.07x |
| AbbVie, Inc. (ABBV) | 3.13% | $255.244B | -5.97% | 68.84% | 5.65x |
| Gilead Sciences, Inc. (GILD) | 3.10% | $98.462B | 0.59% | 77.75% | 4.08x |
| AstraZeneca PLC (AZN) | 3.09% | $198.003B | -2.79% | 73.15% | 5.24x |
| Eli Lilly & Co. (LLY) | 3.09% | $558.335B | 36.84% | 80.42% | 15.62x |
| Amgen, Inc. (AMGN) | 3.08% | $144.964B | 4.36% | 73.71% | 6.40x |
| Vertex Pharmaceuticals, Inc. (VRTX) | 3.02% | $91.259B | 9.33% | 87.15% | 8.30x |
| Becton, Dickinson & Co. (BDX) | 2.96% | $67.839B | 6.85% | 33.44% | 4.68x |
| Bristol Myers Squibb Co. (BMY) | 2.84% | $102.206B | -2.25% | 56.72% | 3.37x |
| Pfizer Inc. (PFE) | 2.84% | $164.254B | -41.55% | 19.87% | 3.02x |
| Biogen, Inc. (BIIB) | 2.82% | $33.264B | 6.20% | 67.78% | 4.44x |
| Shockwave Medical, Inc. (SWAV) | 2.79% | $6.507B | 41.64% | 86.82% | 11.10x |
Market data by FactSet
